2-127651269-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001161417.2(GPR17):c.534G>A(p.Thr178Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00403 in 1,606,540 control chromosomes in the GnomAD database, including 213 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.021 ( 123 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 90 hom. )
Consequence
GPR17
NM_001161417.2 synonymous
NM_001161417.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.97
Genes affected
GPR17 (HGNC:4471): (G protein-coupled receptor 17) Predicted to enable G protein-coupled receptor activity. Predicted to be involved in positive regulation of Rho protein signal transduction and positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway. Predicted to act upstream of or within negative regulation of inflammatory response to antigenic stimulus. Predicted to be located in plasma membrane. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
LIMS2 (HGNC:16084): (LIM zinc finger domain containing 2) This gene encodes a member of a small family of focal adhesion proteins which interacts with ILK (integrin-linked kinase), a protein which effects protein-protein interactions with the extraceullar matrix. The encoded protein has five LIM domains, each domain forming two zinc fingers, which permit interactions which regulate cell shape and migration. A pseudogene of this gene is located on chromosome 4. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 2-127651269-G-A is Benign according to our data. Variant chr2-127651269-G-A is described in ClinVar as [Benign]. Clinvar id is 785853.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.97 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0695 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR17 | NM_001161417.2 | c.534G>A | p.Thr178Thr | synonymous_variant | 2/2 | ENST00000486700.2 | NP_001154889.1 | |
LIMS2 | NM_001161403.3 | c.359+3155C>T | intron_variant | ENST00000355119.9 | NP_001154875.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR17 | ENST00000486700.2 | c.534G>A | p.Thr178Thr | synonymous_variant | 2/2 | 1 | NM_001161417.2 | ENSP00000508383.1 | ||
LIMS2 | ENST00000355119.9 | c.359+3155C>T | intron_variant | 1 | NM_001161403.3 | ENSP00000347240.4 |
Frequencies
GnomAD3 genomes AF: 0.0212 AC: 3221AN: 152168Hom.: 123 Cov.: 33
GnomAD3 genomes
AF:
AC:
3221
AN:
152168
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00561 AC: 1376AN: 245358Hom.: 53 AF XY: 0.00429 AC XY: 571AN XY: 133198
GnomAD3 exomes
AF:
AC:
1376
AN:
245358
Hom.:
AF XY:
AC XY:
571
AN XY:
133198
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00223 AC: 3240AN: 1454254Hom.: 90 Cov.: 32 AF XY: 0.00197 AC XY: 1424AN XY: 723634
GnomAD4 exome
AF:
AC:
3240
AN:
1454254
Hom.:
Cov.:
32
AF XY:
AC XY:
1424
AN XY:
723634
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0212 AC: 3229AN: 152286Hom.: 123 Cov.: 33 AF XY: 0.0200 AC XY: 1493AN XY: 74466
GnomAD4 genome
AF:
AC:
3229
AN:
152286
Hom.:
Cov.:
33
AF XY:
AC XY:
1493
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 13, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at